These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 30229940)

  • 1. How Important Is a Closed-Loop Artificial Pancreas?
    Foltynski P
    Artif Organs; 2019 Jan; 43(1):9-13. PubMed ID: 30229940
    [No Abstract]   [Full Text] [Related]  

  • 2. The First Hybrid Closed-Loop Insulin Pump: Will It Meet Its Potential?
    Hirsch IB
    Diabetes Technol Ther; 2017 Mar; 19(3):140-141. PubMed ID: 28287847
    [No Abstract]   [Full Text] [Related]  

  • 3. The Artificial Pancreas: What School Nurses Need to Know.
    Latham J
    NASN Sch Nurse; 2019 Mar; 34(2):86-89. PubMed ID: 30382764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Learning" Can Improve the Blood Glucose Control Performance for Type 1 Diabetes Mellitus.
    Wang Y; Zhang J; Zeng F; Wang N; Chen X; Zhang B; Zhao D; Yang W; Cobelli C
    Diabetes Technol Ther; 2017 Jan; 19(1):41-48. PubMed ID: 28060528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Closing the Loop on Exercise in Type 1 Diabetes.
    Bally L; Thabit H
    Curr Diabetes Rev; 2018; 14(3):257-265. PubMed ID: 28245784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The artificial pancreas: current status and future prospects in the management of diabetes.
    Peyser T; Dassau E; Breton M; Skyler JS
    Ann N Y Acad Sci; 2014 Apr; 1311():102-23. PubMed ID: 24725149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial Pancreas Device Systems for the Closed-Loop Control of Type 1 Diabetes: What Systems Are in Development?
    Trevitt S; Simpson S; Wood A
    J Diabetes Sci Technol; 2016 May; 10(3):714-23. PubMed ID: 26589628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current topics in glycemic control by wearable artificial pancreas or bedside artificial pancreas with closed-loop system.
    Hanazaki K; Munekage M; Kitagawa H; Yatabe T; Munekage E; Shiga M; Maeda H; Namikawa T
    J Artif Organs; 2016 Sep; 19(3):209-18. PubMed ID: 27142278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin Infusion Sets and Continuous Glucose Monitoring Sensors: Where the Artificial Pancreas Meets the Patient.
    Forlenza GP
    Diabetes Technol Ther; 2017 Apr; 19(4):206-208. PubMed ID: 28418732
    [No Abstract]   [Full Text] [Related]  

  • 10. The artificial pancreas: how close are we to closing the loop?
    Clarke WL; Kovatchev B
    Pediatr Endocrinol Rev; 2007 Jun; 4(4):314-6. PubMed ID: 17643078
    [No Abstract]   [Full Text] [Related]  

  • 11. Overnight Glucose Control with Dual- and Single-Hormone Artificial Pancreas in Type 1 Diabetes with Hypoglycemia Unawareness: A Randomized Controlled Trial.
    Abitbol A; Rabasa-Lhoret R; Messier V; Legault L; Smaoui M; Cohen N; Haidar A
    Diabetes Technol Ther; 2018 Mar; 20(3):189-196. PubMed ID: 29393675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Closed loop insulin delivery in diabetes.
    Battelino T; Omladič JŠ; Phillip M
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):315-25. PubMed ID: 26051293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal control of blood glucose: the diabetic patient or the machine?
    Brown L; Edelman ER
    Sci Transl Med; 2010 Apr; 2(27):27ps18. PubMed ID: 20393187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated hybrid closed-loop control with a proportional-integral-derivative based system in adolescents and adults with type 1 diabetes: individualizing settings for optimal performance.
    Ly TT; Weinzimer SA; Maahs DM; Sherr JL; Roy A; Grosman B; Cantwell M; Kurtz N; Carria L; Messer L; von Eyben R; Buckingham BA
    Pediatr Diabetes; 2017 Aug; 18(5):348-355. PubMed ID: 27191182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-Home Closed Loop Control for Artificial Pancreas: Patient and Provider Perspective.
    Ekhlaspour L; Maahs DM
    Diabetes Technol Ther; 2017 Jan; 19(1):4-6. PubMed ID: 28055224
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical results of an automated artificial pancreas using technosphere inhaled insulin to mimic first-phase insulin secretion.
    Zisser H; Dassau E; Lee JJ; Harvey RA; Bevier W; Doyle FJ
    J Diabetes Sci Technol; 2015 May; 9(3):564-72. PubMed ID: 25901023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Holistic Impact of Closed-Loop Technology on People With Type 1 Diabetes.
    Young AJ; Thabit H; Heller SR; Evans ML; Amiel SA; Hovorka R; Barnard KD
    J Diabetes Sci Technol; 2015 Jul; 9(4):932-3. PubMed ID: 25852073
    [No Abstract]   [Full Text] [Related]  

  • 18. Glucose sensors: toward closed loop insulin delivery.
    Chia CW; Saudek CD
    Endocrinol Metab Clin North Am; 2004 Mar; 33(1):175-95, xi. PubMed ID: 15053902
    [No Abstract]   [Full Text] [Related]  

  • 19. Fully Closed-Loop Multiple Model Probabilistic Predictive Controller Artificial Pancreas Performance in Adolescents and Adults in a Supervised Hotel Setting.
    Forlenza GP; Cameron FM; Ly TT; Lam D; Howsmon DP; Baysal N; Kulina G; Messer L; Clinton P; Levister C; Patek SD; Levy CJ; Wadwa RP; Maahs DM; Bequette BW; Buckingham BA
    Diabetes Technol Ther; 2018 May; 20(5):335-343. PubMed ID: 29658779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Night glucose control with MD-Logic artificial pancreas in home setting: a single blind, randomized crossover trial-interim analysis.
    Nimri R; Muller I; Atlas E; Miller S; Kordonouri O; Bratina N; Tsioli C; Stefanija MA; Danne T; Battelino T; Phillip M
    Pediatr Diabetes; 2014 Mar; 15(2):91-9. PubMed ID: 23944875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.